Pearson delivered higher underlying sales for the third quarter, supported by growth across all divisions, and said it planned to accelerate its artificial-intelligence capabilities to drive further growth.
The pharmaceutical giant raised its full-year guidance for the third time this year after higher third-quarter profit and sales topped analysts' expectations, boosted by revenue from its key drugs.
Vivendi named the management teams and board lineups of the four units into which it plans to split ahead of a shareholders' vote on the breakup project in December.
The chemicals company reported weaker results for the three months through September and cautioned that it didn't expect a significant economic recovery in 2024 due to persistent economic challenges.